Medical Condition

nasopharyngeal carcinoma

Total Trials

13

Recruiting Now

13

Trial Phases

Phase 2, Phase 3, Phase 1

ClinicalMetric tracks all active clinical trials for nasopharyngeal carcinoma sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — nasopharyngeal carcinoma Clinical Trials

How many clinical trials are currently recruiting for nasopharyngeal carcinoma?

ClinicalMetric currently tracks 13 actively recruiting clinical trials for nasopharyngeal carcinoma, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 13. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.

What trial phases are available for nasopharyngeal carcinoma?

nasopharyngeal carcinoma research spans Phase 1 (2 trials), Phase 2 (3 trials), Phase 3 (5 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.

How do I find out if I qualify for a nasopharyngeal carcinoma clinical trial?

Eligibility criteria for nasopharyngeal carcinoma trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.

Trial Phases

Phase 1

Phase 2

Phase 3

Top Sponsors

Sun Yat-sen University 4 trials

National University Hospital, Singapore 1 trial

Zhejiang Cancer Hospital 1 trial

Hunan Cancer Hospital 1 trial

Chongqing University Cancer Hospital 1 trial

Recruiting Clinical Trials

NCT07019870

Recruiting

Screening for Early Diagnosis of Nose Cancer

National University Hospital, ...

View Trial →

NCT05514275 Phase 2

Recruiting

Radiotherapy Combined With Endostatin and Capecitabine for NPC

Zhejiang Cancer Hospital

View Trial →

NCT06321939

Recruiting

Sequencing-based Counting of Plasma Epstein-Barr Virus DNA in Non-metastatic Nasopharyngeal Carcinoma

Hunan Cancer Hospital

View Trial →

NCT06059261 Phase 2

Recruiting

Envafolimab Combined With Chemoradiotherapy and Recombinant Human Endostatin for LA-NPC.

Chongqing University Cancer Ho...

View Trial →

NCT05527470 Phase 3

Recruiting

Induction Chemotherapy Followed by IMRT or Concurrent Chemoradiotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma

Deep Learning-based sbORN Diagnostic Model

Sun Yat-Sen Memorial Hospital ...

View Trial →

NCT07584499 Phase 1

Recruiting

Phase I Study of Becotatug Vedotin for Safety and Efficacy in EGFR-Positive Pediatric Relapsed/Refractory or Metastatic Solid Tumors

Sun Yat-sen University

View Trial →

NCT05877872 Phase 3

Recruiting

Reduced-target Resection After Induction Chemotherapy in Resectable Recurrent Nasopharyngeal Carcinoma

Sun Yat-sen University

View Trial →

NCT06479811 Phase 1

Recruiting

[212Pb]VMT-Alpha-NET in Metastatic or Inoperable Somatostatin-Receptor Positive Gastrointestinal Neuroendocrine Tumors, Pheochromocytoma/Paragangliomas, Small Cell Lung, Renal Cell, and Head and Neck Cancers

National Cancer Institute (NCI...

View Trial →

NCT06912711 Phase 2

Recruiting

TN Induction and Adjuvant Therapy for Resectable Local Recurrent Nasopharyngeal Carcinoma

Sun Yat-sen University

View Trial →

NCT07328854 Phase 3

Recruiting

40.2Gy Versus 49.2Gy Radiotherapy in Low-Risk Target Volume for Chemosensitive Stage II Nasopharyngeal Carcinoma

Individualized Elective Neck Irradiation in NPC Patients

Sun Yat-sen University

View Trial →

NCT06752239 Phase 3

Recruiting

Prophylactic Radiotherapy Optimization for Enhanced Thyroid Function Protection in NPC

Jiangxi Provincial Cancer Hosp...

View Trial →

Related Conditions

herpesvirus 4 human (2) head and neck squamous cell carcinoma hnscc recurrent metastatic r m (1) lymphoepithelial carcinoma (1) rhabdomyosarcoma (1) neuroblastoma (1) medulloblastoma (1) wilms tumor (1) atypical teratoid rhabdoid tumors (1) diffuse intrinsic pontine gliomas (1) other egfr positive pediatric solid tumors deemed eligible by the investigator (1) de escaltion therapy (1) sinonasal neuroendocrine carcinoma (1)

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology